The choice for invasive prenatal tests after subfertility

References

• Ahman, A., Axelsson, O., Maras, G., Rubertsson, C., Sarkadi, A., & Lindgren, P. (2014). Ultrasonographic fetal soft markers in a low-risk population: Prevalence, association with trisomies and invasive tests. Acta Obstetricia et Gynecologica Scandinavica, 93, 367–373. doi: 10.1111/aogs.12334.
   PubMed Web of Science ®Google Scholar
• Alfirevic, Z., Mujezinovic, F., & Sundberg, K. (2003). Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database of Systematic Reviews, 2003, (3), CD003252. doi: 10.1002/14651858.CD003252.
   Google Scholar
• Alsulaiman, A., Hewison, J., Abu-Amero, K., Ahmed, S., Green, J., & Hirst, J. (2012). Attitudes to prenatal diagnosis and termination of pregnancy for 30 conditions among women in Saudi Arabia and the UK. Prenatal Diagnosis, 32, 1109–1113. doi: 10.1002/pd.3967.
   PubMed Web of Science ®Google Scholar
• Baardman, M.E., Du Marchie Sarvaas, G.J., de Walle, H.E.K., Fleurke-Rozema, H., Snijders, R., Ebels, T., … Bakker, M.K. (2014). Impact of introduction of 20-week ultrasound scan on prevalence and fetal and neonatal outcomes in cases of selected severe congenital heart defects in The Netherlands. Ultrasound in Obstetrics & Gynecology, 44, 58–63. doi: 10.1002/uog.13269.
   PubMed Web of Science ®Google Scholar
• Buchanan, A., Sachs, A., Toler, T., & Tsipis, J. (2014). NIPT: Current utilization and implications for the future of prenatal genetic counseling. Prenatal Diagnosis, 34, 850–857. doi: 10.1002/pd.4382.
   PubMed Web of Science ®Google Scholar
• Caleshu, C., Shiloh, S., Price, C., Sapp, J., & Biesecker, B. (2010). Invasive prenatal testing decisions in pregnancy after infertility. Prenatal Diagnosis, 30, 575–581. doi: 10.1002/pd.2529.
   PubMed Web of Science ®Google Scholar
• Elimian, A., Demsky, M., Figueroa, R., Ogburn, P., Spitzer, A.R., & Quirk, J.G. (2003). The influence of IVF, multiple gestation and miscarriage on the acceptance of genetic amniocentesis. Prenatal Diagnosis, 23, 501–503. doi: 10.1002/pd.633.
   PubMed Web of Science ®Google Scholar
• Engels, M.A., Bhola, S.L., Twisk, J.W., Blankenstein, M.A., & Van Vugt, J.M. (2014). Evaluation of the introduction of the national Down syndrome screening program in the Netherlands: Age-related uptake of prenatal screening and invasive diagnostic testing. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 174, 59–63. doi: 10.1016/j.ejogrb.2013.12.009.
   PubMed Web of Science ®Google Scholar
• EUROCAT. (2005). Guide 1.3 and reference documents: Instructions for the Registration and Surveillance of Congenital Anomalies. Retrieved from http://www.eurocat-network.eu/content/EUROCAT-guide-1.3.pdf
   Google Scholar
• Evers, J.L. (2002). Female subfertility. Lancet, 360, 151–159. doi: 10.1016/S0140-6736(02)09417-5..
   PubMed Web of Science ®Google Scholar
• Godino, L., Turchetti, D., & Skirton, H. (2013). A systematic review of factors influencing uptake of invasive fetal genetic testing by pregnant women of advanced maternal age. Midwifery, 29, 1235–1243. doi: 10.1016/j.midw.2012.11.009.
   PubMed Web of Science ®Google Scholar
• Harris, J. (1999). Precious fertility and third-trimester tests. Prenatal Diagnosis, 19, 753–754. doi: 10.1002/(SICI)1097-0223(199908)19:8<753::AID-PD620>3.0.CO;2-S.
   PubMed Web of Science ®Google Scholar
• Hunt, L., Peterson, M., Sinnott, S., Sutton, B., Cincotta, R., Duncombe, G., …, McInerney-Leo, A. (2012). Uptake of invasive prenatal tests in pregnancies conceived via assisted reproductive technologies: the experience in Queensland, Australia. Prenatal Diagnosis, 32, 1049–1052. doi: 10.1002/pd.3953.
   PubMed Web of Science ®Google Scholar
• Johnson, J., & Tough, S., SOGC Genetics Committee. (2012). Delayed child-bearing. Journal of Obstetrics and Gynaecology Canada, 34, 80–93. doi: 10.1016/S1701-2163(16)35138-6.
   PubMedGoogle Scholar
• Kaasen, A., Helbig, A., Malt, U.F., Naes, T., Skari, H., & Haugen, G. (2010). Acute maternal social dysfunction, health perception and psychological distress after ultrasonographic detection of a fetal structural anomaly. BJOG: An International Journal of Obstetrics & Gynaecology, 117, 1127–1138. doi: 10.1111/j.1471-0528.2010.02622.x.
   PubMed Web of Science ®Google Scholar
• Kuppermann, M., Learman, L.A., Gates, E., Gregorich, S.E., Nease Jr R.F., Lewis, J., & Washington, A.E. (2006). Beyond race or ethnicity and socioeconomic status: predictors of prenatal testing for Down syndrome. Obstetrics and Gynecology, 107, 1087–1097. doi: 10.1097/01.AOG.0000214953.90248.db.
   PubMed Web of Science ®Google Scholar
• Lam, Y.H., Tang, M.H., Lee, C.P., Sin, S.Y., Tang, R., Wong, H.S., & Wong, S.F. (2000). Acceptability of serum screening as an alternative to cytogenetic diagnosis of Down syndrome among women 35 years or older in Hong Kong. Prenatal Diagnosis, 20, 487–490. doi: 10.1002/1097-0223(200006)20:6<487::AID-PD853>3.0.CO;2-2.
   PubMed Web of Science ®Google Scholar
• Larion, S., Warsof, S.L., Romary, L., Mlynarczyk, M., Peleg, D., & Abuhamad, A.Z. (2014). Uptake of non-invasive prenatal testing at a large academic referral center. American Journal of Obstetrics & Gynecology, 211, 651.e1– 651.e7. doi: 10.1016/j.ajog.2014.06.038.
   PubMed Web of Science ®Google Scholar
• Lichtenbelt, K.D., Schuring-Blom, G.H., van der Burg, N., Page-Christiaens, G.C., Knoers, N.V., Schielen, P.C., & Koster, M.P. (2013). Factors determining uptake of invasive testing following first-trimester combined testing. Prenatal Diagnosis, 33, 328–333. doi: 10.1002/pd.4067.
   PubMed Web of Science ®Google Scholar
• Marini, T., Sullivan, J., & Naeem, R. (2002). Decisions about amniocentesis by advanced maternal age patients following maternal serum screening may not always correlate clinically with screening results: need for improvement in informed consent process. American Journal of Medical Genetics, 109, 171–175. doi: 10.1002/ajmg.10319.
   PubMed Web of Science ®Google Scholar
• Minkoff, H.L., & Berkowitz, R. (2005). The myth of the precious baby. Obstetrics and Gynecology, 106, 607–609. doi: 10.1097/01.AOG.0000174585.08884.59.
   PubMed Web of Science ®Google Scholar
• NVOG. (2000). Richtlijn: Indicaties voor prenatale diagnostiek. Retrieved from: http://nvog documenten.nl/uploaded/docs/richtlijnen_pdf/28_indica_prenatale_diagno.pdf
   Google Scholar
• RIVM. (2017). Zwangerschapsscreeningen. Retrieved from: http://www.rivm.nl/Onderwerpen/Z/Zwangerschapsscreeningen
   Google Scholar
• Shalev, J., Meizner, I., Rabinerson, D., Mashiach, R., Peleg, D., Orvieto, R., … , Rafael, Z. (1999). Elective cytogenetic amniocentesis in the third trimester for pregnancies with high risk factors. Prenatal Diagnosis, 19, 749–752. doi: 10.1002/(SICI)1097-0223(199908)19:8<749::AID-PD619>3.0.CO;2-#.
   PubMed Web of Science ®Google Scholar
• Sharda, S., & Phadke, S.R. (2007). Uptake of invasive prenatal diagnostic tests in women after detection of soft markers for chromosomal abnormality on ultrasonographic evaluation. Journal of Perinatology, 27, 550–555. doi: 10.1038/sj.jp.7211787.
   PubMed Web of Science ®Google Scholar
• Siljee, J.E., Knegt, A.C., Knapen, M.F., Bekker, M.N., Visser, G.H., & Schielen, P.C. (2014). Positive predictive values for detection of trisomies 21, 18 and 13 and termination of pregnancy rates after referral for advanced maternal age, first trimester combined test or ultrasound abnormalities in a national screening programme (2007-2009). Prenatal Diagnosis, 34, 259–264. doi: 10.1002/pd.4302.
   PubMed Web of Science ®Google Scholar
• Srebnik, N., Miron-Shatz, T., Rolison, J.J., Hanoch, Y., & Tsafrir, A. (2013). Physician recommendation for invasive prenatal testing: The case of the 'precious baby'. Human Reproduction, 28, 3007–3011. doi: 10.1093/humrep/det354.
   PubMed Web of Science ®Google Scholar